Noreen Scherer
Chief Tech/Sci/R&D Officer bei LARIMAR THERAPEUTICS, INC.
Profil
Noreen Scherer is currently the Vice President-Clinical Operations at Larimar Therapeutics, Inc. and Alcobra, Inc. She previously held the same position at Chondrial Therapeutics, Inc. Ms. Scherer completed her undergraduate degree at LaSalle University.
Aktive Positionen von Noreen Scherer
| Unternehmen | Position | Beginn |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.05.2018 |
| Alcobra, Inc. | Chief Operating Officer | - |
Ehemalige bekannte Positionen von Noreen Scherer
| Unternehmen | Position | Ende |
|---|---|---|
Chondrial Therapeutics, Inc.
 Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Noreen Scherer
| LaSalle University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Health Technology |
| Alcobra, Inc. |
